bibt 986
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2002 (NCT02254057)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor XINHIBITOR
F10 inhibitor
- ThrombinINHIBITOR
F2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bibt 986
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02254070 | Phase 1 | Jun 1, 2003 | Boehringer Ingelheim |
| NCT02254083 | Phase 1 | Feb 1, 2003 | Boehringer Ingelheim |
| NCT02259881 | Phase 1 | Dec 1, 2002 | Boehringer Ingelheim |
| NCT02254057 | Phase 1 | Jul 1, 2002 | Boehringer Ingelheim |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 4 | 4 | 1 | 2002 |
1 organizations
Page 1 / 1